Annual Cash & Cash Equivalents
$421.83 M
-$17.66 M-4.02%
December 31, 2022
Summary
- As of February 25, 2025, SLGCW annual cash & cash equivalents is $421.83 million, with the most recent change of -$17.66 million (-4.02%) on December 31, 2022.
- During the last 3 years, SLGCW annual cash & cash equivalents has risen by +$256.89 million (+155.74%).
- SLGCW annual cash & cash equivalents is now -4.02% below its all-time high of $439.49 million, reached on December 31, 2021.
Performance
SLGCW Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$305.57 M
-$48.97 M-13.81%
September 30, 2023
Summary
- As of February 25, 2025, SLGCW quarterly cash and cash equivalents is $305.57 million, with the most recent change of -$48.97 million (-13.81%) on September 30, 2023.
- Over the past year, SLGCW quarterly cash and cash equivalents has stayed the same.
- SLGCW quarterly cash and cash equivalents is now -34.81% below its all-time high of $468.71 million, reached on September 30, 2021.
Performance
SLGCW Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SLGCW Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.0% | 0.0% |
| 3 y3 years | +155.7% | 0.0% |
| 5 y5 years | +155.7% | 0.0% |
SLGCW Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.0% | at low | -30.5% | at low |
| 5 y | 5-year | -4.0% | +155.7% | -34.8% | >+9999.0% |
| alltime | all time | -4.0% | +155.7% | -34.8% | >+9999.0% |
SomaLogic Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $305.57 M(-13.8%) |
| Jun 2023 | - | $354.54 M(-19.1%) |
| Mar 2023 | - | $438.51 M(+4.0%) |
| Dec 2022 | $421.83 M | $421.83 M(+10.9%) |
| Sep 2022 | - | $380.37 M(-9.0%) |
| Jun 2022 | - | $418.18 M(-4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $438.05 M(-0.3%) |
| Dec 2021 | $439.49 M(+166.4%) | $439.49 M(-6.2%) |
| Sep 2021 | - | $468.71 M(+894.3%) |
| Jun 2021 | - | $47.14 M(+2860.8%) |
| Mar 2021 | - | $1.59 M(-99.0%) |
| Dec 2020 | $164.94 M | $164.94 M |
FAQ
- What is SomaLogic annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for SomaLogic?
- What is SomaLogic annual cash & cash equivalents year-on-year change?
- What is SomaLogic quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for SomaLogic?
- What is SomaLogic quarterly cash and cash equivalents year-on-year change?
What is SomaLogic annual cash & cash equivalents?
The current annual cash & cash equivalents of SLGCW is $421.83 M
What is the all time high annual cash & cash equivalents for SomaLogic?
SomaLogic all-time high annual cash & cash equivalents is $439.49 M
What is SomaLogic annual cash & cash equivalents year-on-year change?
Over the past year, SLGCW annual cash & cash equivalents has changed by -$17.66 M (-4.02%)
What is SomaLogic quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SLGCW is $305.57 M
What is the all time high quarterly cash and cash equivalents for SomaLogic?
SomaLogic all-time high quarterly cash and cash equivalents is $468.71 M
What is SomaLogic quarterly cash and cash equivalents year-on-year change?
Over the past year, SLGCW quarterly cash and cash equivalents has changed by $0.00 (0.00%)